Stocks in Action: Evonik, Symrise, AIXTRON, Rheinmetall and Nordex.
Reading Time: 4 minutes
Stock 1.) Evonik - Chemical company continues to suffer from weak demand, Goldman Sachs upgrades from Sell to Buy, price target raised to €18! One of the most important buy ratings comes from Goldman Sachs for Evonik on Tuesday! The specialty chemicals company is currently suffering like other chemical stocks from the gloomy demand environment, increasing competition from China, and high electricity prices, experiencing a revenue decline of 7% to €14.1 billion in the past fiscal year, while adjusted EBITDA fell by 9% to €1.87 billion. Given...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
